Use of Wearables to Detect Infections in Kidney Transplant Recipients
Launched by INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE · Apr 9, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into how wearable devices, like fitness trackers, can help detect infections early in people who have received a kidney transplant. The researchers want to understand how changes in biometric data—such as heart rate, temperature, and activity levels—can signal the onset of an infection before symptoms appear. They will also work on creating a computer program that uses this data to predict infections accurately.
To participate in the study, you must be at least 18 years old, have received a kidney transplant, and have functioning kidney health. Unfortunately, those with certain health conditions, like diabetes type 1 or serious issues with other organs, cannot join. If you are eligible and decide to participate, you'll use your own wearable device to track your health data throughout the study. The goal is to improve how infections are detected in kidney transplant recipients, ultimately helping to keep you and others healthier after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • kidney transplant recipient
- • age 18 years or more
- • kidney allograft function (eGFR based on CKD-EPI more than 15ml/min/1.73m2)
- Exclusion Criteria:
- • recipient of another transplanted organ
- • terminal failure of another organ (heart, liver, lung)
- • diabetes mellitus type 1
- • pregnant or breastfeeding woman
- • refusal to give informed consent
About Institute For Clinical And Experimental Medicine
The Institute for Clinical and Experimental Medicine (IKEM) is a leading research institution dedicated to advancing healthcare through innovative clinical and experimental studies. With a strong emphasis on translational research, IKEM aims to bridge the gap between laboratory discoveries and clinical applications, fostering collaboration among scientists, healthcare professionals, and industry partners. Its state-of-the-art facilities and multidisciplinary approach enable robust investigations into a wide range of medical conditions, ultimately striving to improve patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Prague, , Czechia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported